Delivery Order SPE2DB24D3013-SPE2DB25FFLJX

Award Date 5/1/25
Potential Completion Date 5/2/25
Potential Value $3.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Orencia 125 mg/ml syringes, with a ceiling value of $84,996.81 and a period of performance through April 15, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 125 mg/mL Orencia syringes. The contract has a firm fixed price of $3,907.97 and a period of performance through July 8, 2024. It is a delivery order contract type, with no set-aside requirements indicated. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 125 mg/mL Orencia syringes, a specialty medication, with a ceiling value of $3,287.42 and a completion date of June 21, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,313.48 firm-fixed-price contract is for the supply of Orencia 125 mg/mL syringes, with a completion date of November 22, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, awarded on March 5, 2024, is for the delivery of Orencia 125 mg/ml syringes, with a ceiling value of $3,632.50 and a completion date of March 6, 2024. This is a firm fixed-price delivery order contract with no set-aside designation. AmerisourceBergen holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,640.93 delivery order contract is for the supply of Orencia Clickject 125 mg/ml, a pharmaceutical product, with a period of performance through April 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Orencia 125 mg/mL syringes, a specialty medication, to support military healthcare programs. The contract has a ceiling value of $12,043.68 and a period of performance through July 2024. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $31,271.73, is for the delivery of Orencia 125 mg/ml syringes. It is a firm-fixed price contract with a performance period through March 4, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Orencia 125 mg/ml syringes. The contract has a ceiling value of $15,354.82 and an ultimate completion date of August 22, 2024. Amerisourcebergen holds significant Indefinite Delivery Contracts (IDCs) with DLA Troop Support Medical and the Department of Justice Federal Bureau of Investigation, valued at up to...
This federal contract award, valued at $3,640.92, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Orencia Clickject 125 mg/ml, a pharmaceutical product. This is a firm-fixed-price delivery order contract with an ultimate completion date of April 28, 2025. The contract is not set-aside and is open to competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite...
  • SPE2DB24D3013
    Indefinite Delivery Contract
  • SPE2DB24D3013-SPE2DB25FFLJX
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $3,861.05, is for the delivery of 125 mg/mL Orencia syringes. The contract is a firm fixed-price, non-set-aside award with a performance period ending on May 2, 2025.

AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including customers such as the Defense Health Agency and U.S. Coast Guard.

Generated 7/31/25, 10:08 AM